Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of ...

Adverum Biotechnologies advances wet AMD treatment with promising trial results. See why ADVM stock has potential as it ...

Wet AMD is caused by an overgrowth of blood vessels in the retina, the light-sensing tissue at the back of the eye. The ...

Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition ...

Dry age-related macular degeneration accounts for about 80 percent of AMD cases, reports the AAO. With dry AMD, the macula gets thinner with age and small deposits of protein (called drusen ...

D Molecular Therapeutics, Inc. ( (FDMT) ) has released its Q3 earnings. Here is a breakdown of the information 4D Molecular Therapeutics, Inc.

24 (UPI) --Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the development and progression of age-related macular degeneration ...

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says. The therapy, called photobiomodulation or "red light" therapy, can reduce ...

Age-related macular degeneration can have severe effects, but treatments for the condition are available. (Getty Images) Have your parents or grandparents ever had trouble driving, reading or ...